Literature DB >> 11765841

Management of idiopathic normal-pressure hydrocephalus: a multiinstitutional study conducted in Japan.

K Mori1.   

Abstract

OBJECT: A cooperative study was undertaken to identify factors that could be used to predict a favorable outcome after extracranial cerebrospinal fluid (CSF) diversion (shunting) in patients with suspected idiopathic normal-pressure hydrocephalus (NPH).
METHODS: Questionnaires concerning patients with suspected idiopathic NPH were sent to 14 members of the Committee for Scientific Research on Intractable Hydrocephalus, sponsored by the Ministry of Health and Welfare of Japan. After the questionnaires were returned, a retrospective analysis of the responses was undertaken. To be included in the study, patients had to be 65 years of age or older and had to have undergone surgery between October 1995 and October 1998. Clinical measures included degrees of gait disturbance, dementia, and urinary incontinence as evaluated before. 3 months after, and 3 years after shunt placement. Diagnostic tests in various combinations included lumbar puncture in which CSF was withdrawn; intracranial pressure monitoring; measurements of CSF outflow resistance, level of serum alpha-1-antichymotrypsin, cerebral arteriovenous differences of oxygen content, and cerebral blood flow; and computerized tomography cisternography. In this study, 120 patients were identified as having idiopathic NPH and these patients underwent placement of shunts. A ventriculoperitoneal shunt with a programmable valve was used in two thirds of the patients. At the end of 3 months (early assessment), there was an 80% overall rate of clinical improvement, which dropped to 73.3% of the 105 patients who could be evaluated at the end of the 3-year study. Of the three variables, gait disturbance was most improved, both at early and late testing periods. Shunt complications occurred in 22 (18.3%) of the patients.
CONCLUSIONS: Patients suspected of having idiopathic NPH did not form a homogeneous group, making it difficult to select those who would most likely respond to CSF diversion. Of the diagnostic studies, the most reliable result was improvement in clinical symptoms following a lumbar puncture in which CSF was withdrawn. The use of a programmable valve is recommended because it offers advantages in preventing problems of over- and underdrainage.

Entities:  

Mesh:

Year:  2001        PMID: 11765841     DOI: 10.3171/jns.2001.95.6.0970

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  24 in total

1.  Bladder recovery relates with increased mid-cingulate perfusion after shunt surgery in idiopathic normal-pressure hydrocephalus: a single-photon emission tomography study.

Authors:  Ryuji Sakakibara; Yoshitaka Uchida; Kazunari Ishii; Masaaki Hashimoto; Masaaki Ishikawa; Hiromitsu Kazui; Tatsuya Yamamoto; Tomoyuki Uchiyama; Fuyuki Tateno; Masahiko Kishi; Yohei Tsuyusaki; Yosuke Aiba; Hiromi Tateno; Takeki Nagao; Hitoshi Terada; Tsutomu Inaoka
Journal:  Int Urol Nephrol       Date:  2015-11-17       Impact factor: 2.370

2.  Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting.

Authors:  R Bech-Azeddine; P Høgh; M Juhler; F Gjerris; G Waldemar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-29       Impact factor: 10.154

3.  Alteration of brain viscoelasticity after shunt treatment in normal pressure hydrocephalus.

Authors:  Florian Baptist Freimann; Kaspar-Josche Streitberger; Dieter Klatt; Kui Lin; Joyce McLaughlin; Jürgen Braun; Christian Sprung; Ingolf Sack
Journal:  Neuroradiology       Date:  2011-05-03       Impact factor: 2.804

4.  Is the midbrain involved in the manifestation of gait disturbance in idiopathic normal-pressure hydrocephalus?

Authors:  Kotaro Hiraoka; Hiroshi Yamasaki; Masahito Takagi; Makoto Saito; Yoshiyuki Nishio; Osamu Iizuka; Shigenori Kanno; Hirokazu Kikuchi; Etsuro Mori
Journal:  J Neurol       Date:  2010-12-04       Impact factor: 4.849

5.  Normal pressure hydrocephalus: how often does the diagnosis hold water?

Authors:  Bryan T Klassen; J Eric Ahlskog
Journal:  Neurology       Date:  2011-08-17       Impact factor: 9.910

6.  Shunt-responsive parkinsonism and reversible white matter lesions in patients with idiopathic NPH.

Authors:  Ichiro Akiguchi; Mitsuaki Ishii; Yuko Watanabe; Toshiyuki Watanabe; Teruaki Kawasaki; Hideo Yagi; Akihiko Shiino; Yoshitomo Shirakashi; Yasuhiro Kawamoto
Journal:  J Neurol       Date:  2008-06-27       Impact factor: 4.849

7.  A pressure adjustment protocol for programmable valves.

Authors:  Kyoung-Hun Kim; In-Seoung Yeo; Jin-Seok Yi; Hyung-Jin Lee; Ji-Ho Yang; Il-Woo Lee
Journal:  J Korean Neurosurg Soc       Date:  2009-10-31

8.  Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus.

Authors:  Madoka Nakajima; Shigeki Yamada; Masakazu Miyajima; Kazunari Ishii; Nagato Kuriyama; Hiroaki Kazui; Hideki Kanemoto; Takashi Suehiro; Kenji Yoshiyama; Masahiro Kameda; Yoshinaga Kajimoto; Mitsuhito Mase; Hisayuki Murai; Daisuke Kita; Teruo Kimura; Naoyuki Samejima; Takahiko Tokuda; Mitsunobu Kaijima; Chihiro Akiba; Kaito Kawamura; Masamichi Atsuchi; Yoshihumi Hirata; Mitsunori Matsumae; Makoto Sasaki; Fumio Yamashita; Shigeki Aoki; Ryusuke Irie; Hiroji Miyake; Takeo Kato; Etsuro Mori; Masatsune Ishikawa; Isao Date; Hajime Arai
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-01-15       Impact factor: 1.742

9.  Evaluation of autonomic malfunction in idiopathic normal pressure hydrocephalus.

Authors:  Nagato Kuriyama; Takahiko Tokuda; Masaki Kondo; Junichi Miyamoto; Kei Yamada; Yo Ushijima; So Ushijima; Natsuko Takayasu; Fumitoshi Niwa; Masanori Nakagawa
Journal:  Clin Auton Res       Date:  2008-07-23       Impact factor: 5.625

Review 10.  Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH).

Authors:  Katarina Ivana Tudor; Mario Tudor; Jenny McCleery; Josip Car
Journal:  Cochrane Database Syst Rev       Date:  2015-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.